Personalized medicine, driven by advancements in computational methods and predictive analytics, has emerged as a revolutionary approach to healthcare. This review provides an in depth exploration of the foundations, key principles, and computational techniques that underpin personalized medicine. It highlights the significance of personalized medicine in tailoring treatments to individual patients, optimizing healthcare outcomes, and enhancing the quality of care. Additionally, this review discusses the challenges and future prospects of personalized medicine in the context of predictive analytics, offering insights into the evolving landscape of healthcare. Transitioning from the foundational understanding of personalized medicine, we delve into the pivotal role of predictive analytics within this paradigm. Predictive analytics, a branch of data science, is the driving force behind the precision and individualization inherent in personalized medicine. It harnesses the power of advanced computational methods and algorithms to process vast datasets and generate predictions about future events, in this case, patient outcomes and treatment responses. Snowza Chrysolite. D "Personalized Medicine and Predictive Analytics: A Review of Computational Methods" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-7 | Issue-5 , October 2023, URL: https://www.ijtsrd.com/papers/ijtsrd59982.pdf Paper Url: https://www.ijtsrd.com/medicine/other/59982/personalized-medicine-and-predictive-analytics-a-review-of-computational-methods/snowza-chrysolite-d
2. International Journal of Trend in Scientific Research and Development @ www.ijtsrd.com eISSN: 2456-6470
@ IJTSRD | Unique Paper ID – IJTSRD59982 | Volume – 7 | Issue – 5 | Sep-Oct 2023 Page 550
intricate interplay between predictive analytics and
personalized medicine, shedding light on the
methodologies and computational techniques that
drive precise healthcare interventions. Finally, we
outline the scope of this review, delineating the key
topics and themes that will be covered, and
emphasizing the overarching objective of providing a
comprehensive understanding of the symbiotic
relationship between personalized medicine and
predictive analytics.
In the realm of personalized medicine, understanding
its definition and recognizing its significance are
fundamental starting points. Personalized medicine,
often interchangeably referred to as precision
medicine, represents a holistic approach to patient
care that considers individual variability in genes,
environment, and lifestyle. It fundamentally
challenges the traditional one-size-fits-all model of
healthcare by acknowledging that patients with
identical diagnoses may respond differently to
treatments based on their unique biological makeup
and life circumstances.
The significance of personalized medicine lies in its
potential to revolutionize healthcare on multiple
fronts. First and foremost, it has the power to improve
patient outcomes by tailoring treatments to the
specific needs and characteristics of each patient. This
approach minimizes the likelihood of adverse
reactions and ineffective therapies, enhancing the
overall quality of care. Moreover, personalized
medicine has the capacity to accelerate drug
discovery and development by identifying suitable
patient populations for clinical trials and expediting
the evaluation of drug efficacy. This not only reduces
the cost and time associated with drug development
but also increases the likelihood of bringing more
effective therapies to market.
Furthermore, personalized medicine has a profound
impact on disease prevention and early intervention.
By assessing an individual's genetic predispositions
and environmental factors, healthcare providers can
proactively identify disease risks and implement
preventive measures, potentially averting the onset of
serious health conditions. Additionally, personalized
medicine empowers patients to take an active role in
their healthcare decisions, fostering a more patient-
centered approach to medicine.
Predictive analytics plays a multifaceted role in
personalized medicine, starting with risk assessment
and disease prediction. By analyzing an individual's
genetic makeup, medical history, and lifestyle data,
predictive models can estimate a person's
susceptibility to certain diseases. For example,
genomic sequencing can identify genetic variants
associated with a heightened risk of conditions such
as cardiovascular disease or certain cancers. Armed
with this information, healthcare providers can
develop personalized prevention strategies and early
intervention plans.
Moreover, predictive analytics extends to treatment
optimization. Healthcare professionals can employ
predictive models to determine the most effective
treatment options for a particular patient. This
involves assessing how a patient is likely to respond
to various therapies based on their genetic and clinical
profiles. For instance, in oncology, predictive
analytics can aid in selecting the most suitable
chemotherapy regimen for a cancer patient, taking
into account factors such as drug metabolism and
potential side effects.
Additionally, predictive analytics contributes to
patient monitoring and disease management.
Continuous data collection through wearable devices
and remote sensors allows for real-time health
tracking. Predictive models can analyze this data to
detect early warning signs of health deterioration and
recommend timely interventions. This is particularly
valuable for chronic diseases, where proactive
management can enhance the patient's quality of life.
The purpose of this review is to provide an in-depth
exploration of the intricate relationship between
personalized medicine and predictive analytics. By
examining the foundational principles and
significance of personalized medicine, we establish
the context for the critical role that predictive
analytics plays in this emerging healthcare paradigm.
We aim to elucidate the methodologies, tools, and
techniques used in predictive analytics within the
realm of personalized medicine. Furthermore, we
intend to analyze real-world applications and case
studies that showcase the tangible benefits and
challenges of integrating predictive analytics into
clinical practice.
The scope of this review encompasses various
dimensions of personalized medicine and predictive
analytics. We will delve into the methodologies
employed in predictive analytics, ranging from
machine learning algorithms to statistical modeling
approaches. We will explore the data sources and
types that feed into predictive models, including
electronic health records, genomic data, imaging data,
and wearable device data. Case studies and examples
from different medical domains will be examined to
highlight successful applications and potential areas
for improvement.
Moreover, this review will address ethical
considerations and regulatory frameworks
3. International Journal of Trend in Scientific Research and Development @ www.ijtsrd.com eISSN: 2456-6470
@ IJTSRD | Unique Paper ID – IJTSRD59982 | Volume – 7 | Issue – 5 | Sep-Oct 2023 Page 551
surrounding the use of predictive analytics in
personalized medicine, emphasizing the importance
of patient privacy, informed consent, and compliance
with healthcare regulations.
Historical development and evolution
Key principles and concepts lie at the heart of
personalized medicine, driving its development and
implementation in modern healthcare. These
principles encompass fundamental ideas and
approaches that guide the delivery of patient-centered
care and the customization of medical interventions.
In parallel, personalized medicine brings forth a
multitude of benefits while also presenting notable
challenges that must be addressed to fully realize its
potential.
Key Principles and Concepts
Individualized Care: At the core of personalized
medicine is the recognition that each patient is
unique. This principle emphasizes the importance of
tailoring medical treatments to the specific genetic,
environmental, and lifestyle characteristics of each
individual. By doing so, healthcare providers can
maximize treatment effectiveness while minimizing
potential adverse effects.
Genomic Profiling: Genomic information is a
cornerstone of personalized medicine. The human
genome, comprising all the genetic material in an
individual, provides a wealth of data that can be
analyzed to identify genetic variations associated with
disease susceptibility, treatment response, and drug
metabolism. Genomic profiling enables clinicians to
make informed decisions regarding patient care.
Predictive Analytics: Predictive analytics plays a
pivotal role in personalized medicine by forecasting
patient outcomes and treatment responses. Through
the use of computational methods and algorithms,
predictive models can assess a patient's risk of
developing specific diseases, estimate the
effectiveness of treatment options, and monitor health
parameters in real time.
Targeted Therapies: Personalized medicine
promotes the development of targeted therapies,
which are designed to act on specific molecular
pathways or genetic mutations implicated in a
patient's condition. By precisely targeting the
underlying causes of a disease, these therapies can
improve treatment outcomes and reduce side effects.
Precision Diagnostics: Accurate and early diagnosis
is essential for personalized medicine. Advanced
diagnostic tools, including genetic testing, biomarker
analysis, and imaging techniques, enable healthcare
providers to identify diseases at their earliest stages
and tailor interventions accordingly.
Patient-Centered Care: Personalized medicine
places the patient at the center of healthcare decision-
making. Informed consent, shared decision-making,
and open communication between patients and
healthcare providers are integral to this approach.
Patients are actively engaged in selecting treatment
options that align with their values and preferences.
Benefits and Challenges
Benefits
Enhanced Treatment Efficacy: Personalized
medicine enables the selection of treatments that are
more likely to be effective for a specific patient,
reducing the trial-and-error approach to medical
interventions. This leads to improved patient
outcomes and a higher likelihood of successful
treatment.
Reduced Adverse Effects: By tailoring treatments to
individual characteristics, personalized medicine
minimizes the risk of adverse effects and toxicity.
Patients experience fewer side effects, leading to
better quality of life during treatment.
Early Disease Detection: Precise diagnostic tools in
personalized medicine can detect diseases at their
earliest stages, often before symptoms manifest. This
facilitates early intervention and increases the chances
of successful treatment and cure.
Optimized Drug Development: Pharmaceutical
companies benefit from personalized medicine by
identifying target populations for clinical trials and
drug development. This streamlines the drug
discovery process, reduces costs, and accelerates the
availability of new therapies.
Improved Healthcare Economics: Personalized
medicine has the potential to reduce healthcare costs
in the long run by avoiding unnecessary treatments,
hospitalizations, and adverse events. It promotes
efficient resource allocation in healthcare.
Patient Empowerment: Patients are empowered
through personalized medicine to actively participate
in their healthcare decisions. They have access to
information about their genetic predispositions, which
allows them to make informed choices about
prevention and treatment.
Challenges
Data Privacy and Security: The vast amount of
personal health data, including genomic information,
collected for personalized medicine raises concerns
about data privacy and security. Safeguarding
sensitive patient data is paramount to ensure patient
trust and compliance with personalized medicine
approaches.
4. International Journal of Trend in Scientific Research and Development @ www.ijtsrd.com eISSN: 2456-6470
@ IJTSRD | Unique Paper ID – IJTSRD59982 | Volume – 7 | Issue – 5 | Sep-Oct 2023 Page 552
Ethical Considerations: Ethical dilemmas may arise
in personalized medicine, such as the disclosure of
genetic information, informed consent for genetic
testing, and potential discrimination based on genetic
predispositions. Ethical guidelines and regulations
must address these concerns.
Cost and Accessibility: Some personalized medicine
interventions, especially genomic testing and targeted
therapies, can be expensive. Ensuring equitable
access to these treatments for all patients is a
challenge in healthcare systems with limited
resources.
Regulatory Frameworks: Developing regulatory
frameworks that accommodate the rapid
advancements in personalized medicine can be
challenging. Regulatory agencies must adapt to
evaluate and approve treatments tailored to specific
genetic profiles.
Data Integration: Integrating diverse data sources,
such as electronic health records, genomics data, and
real-time monitoring data, can be complex.
Establishing interoperability standards and data-
sharing agreements is essential for comprehensive
personalized medicine.
Education and Training: Healthcare professionals
require specialized training to effectively implement
personalized medicine. Continuous education and
skill development are necessary to keep up with
evolving technologies and treatment approaches.
Predictive Analytics in Healthcare
Predictive analytics, a powerful field of data analysis
and modeling, has emerged as a critical component of
healthcare and medicine, particularly in the context of
personalized medicine. This transformative approach
harnesses the predictive capabilities of advanced
computational techniques to anticipate patient
outcomes, identify disease risk factors, and guide
clinical decision-making. This overview delves into
the fundamental aspects of predictive analytics,
explores its diverse applications in healthcare and
medicine, and underscores its pivotal role in the realm
of personalized medicine.
Overview of Predictive Analytics
Predictive analytics is a multidisciplinary field that
combines data science, statistics, machine learning,
and artificial intelligence to extract meaningful
insights from data and make informed predictions
about future events or trends. At its core, predictive
analytics leverages historical and real-time data to
develop mathematical models, algorithms, and
predictive scores that assist in decision-making.
These models are capable of identifying patterns,
relationships, and trends within datasets, enabling
organizations and professionals to make data-driven
choices.
Applications in Healthcare and Medicine
Predictive analytics has found extensive applications
in healthcare and medicine due to its ability to
improve patient care, optimize resource allocation,
and enhance clinical outcomes. Some key
applications include:
Risk Stratification: Predictive analytics is used to
stratify patients based on their risk of developing
specific diseases or experiencing adverse events. For
example, it can identify individuals at high risk of
heart disease, allowing for early intervention and
tailored prevention strategies.
Disease Prediction and Early Detection: Predictive
models analyze patient data, such as genetic
information, medical history, and lifestyle factors, to
predict disease susceptibility and facilitate early
detection. This is particularly valuable in oncology,
where predictive analytics aids in identifying cancer
risks and recommending screening protocols.
Clinical Decision Support: Healthcare providers rely
on predictive analytics to support clinical decision-
making. Algorithms can assist in diagnosing diseases,
recommending treatment options, and predicting
patient responses to specific therapies.
Resource Allocation: Hospitals and healthcare
systems use predictive analytics to optimize resource
allocation. This includes predicting patient admission
rates, determining staffing needs, and managing
inventory levels for medical supplies.
Population Health Management: Predictive
analytics helps in managing population health by
identifying at-risk populations, monitoring chronic
disease management, and developing targeted
interventions to improve health outcomes.
Patient Readmission Prediction: Hospitals use
predictive models to predict patient readmissions.
This enables proactive interventions to prevent
avoidable hospital readmissions, reducing healthcare
costs and improving patient care.
Drug Discovery and Development: In
pharmaceutical research, predictive analytics
accelerates drug discovery by identifying potential
drug candidates and predicting their safety and
efficacy profiles. This streamlines the drug
development process.
Importance in Personalized Medicine
Predictive analytics plays a pivotal role in
personalized medicine, aligning with its core
principles of individualized care and targeted
5. International Journal of Trend in Scientific Research and Development @ www.ijtsrd.com eISSN: 2456-6470
@ IJTSRD | Unique Paper ID – IJTSRD59982 | Volume – 7 | Issue – 5 | Sep-Oct 2023 Page 553
therapies. Here's how predictive analytics contributes
to personalized medicine:
Treatment Personalization: Predictive models
analyze patient-specific data, including genetic
information, to tailor treatment plans. This ensures
that treatments are chosen based on the patient's
genetic profile, optimizing efficacy and minimizing
adverse effects.
Drug Selection: In pharmacogenomics, predictive
analytics helps identify genetic variants that influence
how individuals metabolize drugs. This information
guides healthcare providers in selecting the most
appropriate medications and dosages for each patient.
Treatment Response Prediction: Predictive
analytics assesses a patient's likelihood of responding
to a particular treatment, allowing clinicians to make
informed decisions about therapy initiation,
modification, or discontinuation.
Preventive Interventions: Predictive models identify
individuals at high risk of certain diseases, enabling
proactive preventive interventions. Patients can
receive personalized recommendations for lifestyle
changes, screenings, and vaccinations.
Clinical Trials: Predictive analytics assists in patient
stratification for clinical trials. By identifying
participants most likely to benefit from an
investigational therapy, trials become more efficient,
and the results are more applicable to specific patient
groups.
Computational Methods for Predictive Analytics
Machine learning algorithms are the backbone of
predictive analytics, playing a central role in
analyzing data, making predictions, and automating
decision-making processes. Within the realm of
healthcare and personalized medicine, machine
learning offers a diverse array of algorithms and
techniques to extract valuable insights from medical
data. This overview delves into key aspects of
machine learning, including supervised and
unsupervised learning, deep learning, statistical
modeling approaches, and the critical steps of data
preprocessing and feature selection.
Machine Learning Algorithms
Machine learning algorithms are computer programs
that can learn from data, recognize patterns, and make
predictions or decisions without explicit
programming. These algorithms encompass various
categories, each suited to specific tasks and data
types:
Supervised Learning: In supervised learning,
algorithms are trained on labeled data, which means
that each data point is associated with a target
outcome or label. The goal is to learn a mapping
function that can predict the correct labels for new,
unseen data. Common supervised learning algorithms
include decision trees, random forests, support vector
machines, and neural networks.
Unsupervised Learning: Unsupervised learning
deals with unlabeled data, where the algorithm seeks
to uncover patterns, structures, or relationships within
the data without predefined categories. Clustering and
dimensionality reduction are typical tasks in
unsupervised learning. K-means clustering,
hierarchical clustering, and principal component
analysis (PCA) are examples of unsupervised
algorithms.
Deep Learning: Deep learning is a subset of machine
learning that focuses on artificial neural networks
with multiple layers (deep neural networks). These
networks are particularly well-suited for tasks
involving large and complex datasets, such as image
and speech recognition. Convolutional neural
networks (CNNs) and recurrent neural networks
(RNNs) are popular deep learning architectures.
Statistical Modeling Approaches: Statistical
modeling encompasses a wide range of techniques,
from linear regression to Bayesian methods. These
models are used to describe and analyze relationships
between variables in a probabilistic framework. In
healthcare, statistical models are often used for risk
prediction, outcome modeling, and epidemiological
studies.
Data Preprocessing and Feature Selection: Data
preprocessing is a crucial step in machine learning. It
involves cleaning and transforming data to make it
suitable for analysis. Feature selection, a subset of
data preprocessing, focuses on identifying the most
relevant variables (features) for a particular task.
Techniques like data imputation, normalization, and
dimensionality reduction are commonly applied
during preprocessing.
Machine learning algorithms have a profound impact
on personalized medicine by enabling the analysis of
complex patient data, such as genomic information,
electronic health records, and medical imaging.
Here's how these aspects of machine learning apply in
the context of personalized medicine:
Supervised Learning in Genomic Medicine:
Genomic data, including DNA sequencing, can be
analyzed using supervised learning algorithms to
identify genetic variants associated with diseases.
These algorithms predict disease risk, drug responses,
and treatment outcomes based on a patient's genetic
profile.
6. International Journal of Trend in Scientific Research and Development @ www.ijtsrd.com eISSN: 2456-6470
@ IJTSRD | Unique Paper ID – IJTSRD59982 | Volume – 7 | Issue – 5 | Sep-Oct 2023 Page 554
Unsupervised Learning in Patient Stratification:
Unsupervised learning techniques, like clustering, are
used to group patients with similar characteristics.
This facilitates patient stratification for personalized
treatment plans, identifying subpopulations that may
respond differently to therapies.
Deep Learning in Medical Imaging: Deep learning,
particularly CNNs, has revolutionized medical
imaging analysis. It aids in the early detection of
diseases by accurately interpreting radiological
images, such as X-rays, MRIs, and CT scans. These
models can identify anomalies and assist in disease
diagnosis.
Statistical Models in Clinical Trials: Statistical
models are applied in the design and analysis of
clinical trials, helping to determine the efficacy of
personalized treatments. They assess the impact of
patient characteristics, treatment protocols, and
covariates on trial outcomes.
Data Preprocessing and Feature Selection for
Precision Medicine: Data preprocessing and feature
selection are critical in genomic and clinical data
analysis. They help identify relevant biomarkers,
filter noise, and ensure that input data are suitable for
machine learning models.
Data Sources and Types
In the era of personalized medicine, diverse data
sources and types play a pivotal role in providing
comprehensive insights into a patient's health and
facilitating tailored treatment strategies. These
sources encompass electronic health records (EHRs),
genomic data, imaging data, wearable device data,
and other relevant sources, collectively contributing
to a holistic understanding of an individual's health
profile.
Electronic Health Records (EHRs)
Electronic health records are digital versions of a
patient's medical history, comprising a wealth of
information collected during healthcare encounters.
EHRs include:
Demographic Information: Patient demographics,
such as age, gender, and contact details.
Medical History: Details of past illnesses, surgeries,
hospitalizations, and chronic conditions.
Medication Records: Information about prescribed
medications, dosages, and adherence.
Laboratory Results: Data from blood tests, urine
tests, and other diagnostic analyses.
Radiology Reports: Reports from medical imaging
studies, including X-rays, MRIs, and CT scans.
Clinical Notes: Notes and observations recorded by
healthcare providers during patient visits.
Allergies and Adverse Reactions: Information about
known allergies and adverse reactions to medications.
EHRs serve as a centralized repository of patient data,
allowing healthcare providers to access
comprehensive patient information for diagnosis,
treatment planning, and monitoring.
Genomic Data
Genomic data encompasses an individual's genetic
information, particularly their DNA sequence. This
data type provides insights into the genetic variations
that influence susceptibility to diseases, response to
treatments, and potential adverse reactions. Key
components of genomic data include:
Genomic Sequencing: The complete DNA sequence
of an individual, including coding and non-coding
regions.
Single Nucleotide Polymorphisms (SNPs):
Variations in single nucleotides (A, T, C, or G) that
can affect gene function.
Copy Number Variations (CNVs): Changes in the
number of copies of specific genes or genomic
segments.
Gene Expression Profiles: Information about how
genes are expressed and regulated in specific tissues
or conditions.
Genomic data enables personalized medicine by
guiding treatment decisions based on a patient's
genetic profile, allowing for tailored therapies and
targeted interventions.
Imaging Data
Imaging data encompasses a wide range of medical
images acquired through various imaging modalities.
These include:
X-rays: Used for bone and tissue imaging, such as
detecting fractures or lung conditions.
Computed Tomography (CT): Provides detailed
cross-sectional images of the body's internal
structures.
Magnetic Resonance Imaging (MRI): Offers high-
resolution images for soft tissue evaluation.
Ultrasound: Utilized for real-time imaging of organs
and blood flow.
Positron Emission Tomography (PET) and Single
Photon Emission Computed Tomography
(SPECT): Used for functional imaging and cancer
staging.
7. International Journal of Trend in Scientific Research and Development @ www.ijtsrd.com eISSN: 2456-6470
@ IJTSRD | Unique Paper ID – IJTSRD59982 | Volume – 7 | Issue – 5 | Sep-Oct 2023 Page 555
Imaging data aids in disease diagnosis, treatment
planning, and monitoring, allowing healthcare
providers to visualize and assess anatomical and
physiological changes.
Wearable Device Data
Wearable devices, such as smartwatches and fitness
trackers, generate continuous streams of data related
to an individual's health and activities. These devices
collect data such as:
Heart Rate and Blood Pressure: Monitoring vital
signs and cardiovascular health.
Physical Activity: Tracking steps taken, distance
traveled, and exercise patterns.
Sleep Patterns: Analyzing sleep duration and
quality.
Environmental Exposures: Measuring exposure to
pollutants, UV radiation, and other environmental
factors.
Wearable device data provides real-time insights into
a patient's daily life and can be used for preventive
care, early disease detection, and lifestyle
interventions.
Other Relevant Sources
In addition to the aforementioned data sources,
personalized medicine may also incorporate data from
other relevant sources, including:
Social Determinants of Health: Socioeconomic
factors, housing conditions, and community
environments that impact health outcomes.
Pharmacogenomic Databases: Repositories of
genetic information related to drug responses and
metabolism.
Patient-Reported Outcomes: Data collected directly
from patients regarding their symptoms, quality of
life, and treatment preferences.
Biosensors and Remote Monitoring: Data from
implanted or external sensors that continuously
monitor physiological parameters, such as glucose
levels in diabetes management.
These diverse data sources are integral to the practice
of personalized medicine, enabling healthcare
providers to create a holistic patient profile and make
informed decisions tailored to individual health
needs. The integration and analysis of these data
types are pivotal in realizing the full potential of
personalized medicine, offering the promise of
improved patient outcomes and enhanced healthcare
delivery.
References
[1] Bertram, L., & Tanzi, R. E. (2005). The genetic
epidemiology of neurodegenerative disease.
The Journal of Clinical Investigation, 115(6),
1449–1457. [PubMed Central]
[2] Chen, J. J., Lu, T. P., Chen, Y. C., & Lin, W. J.
(2015). Predictive biomarkers for treatment
selection: Statistical considerations. Biomarkers
in Medicine, 9(11), 1121–1135. [PubMed]
[3] de Langavant, L. C., Bayen, E., & Yaffe, K.
(2018). Unsupervised machine learning to
identify high likelihood of dementia in
population-based surveys: Development and
validation study. Journal of Medical Internet
Research, 20(7), e10493. [Google Scholar]
[4] Cipresso, P. (2015). Modeling behavior
dynamics using computational psychometrics
within virtual worlds. Frontiers in Psychology,
6, 1725. [PubMed Central]
[5] Das, S., Dey, A., Pal, A., & Roy, N. (2015).
Applications of artificial intelligence in
machine learning: Review and Prospect.
International Journal of Computer Applications,
115(9), 31–41. [Google Scholar]
[6] Dallora, A. L., Eivazzadeh, S., Mendes, E.,
Berglund, J., & Anderberg, P. (2017). Machine
learning and microsimulation techniques on the
prognosis of dementia: A systematic literature
review. PLoS One, 12(6), e0179804. [PubMed
Central]
[7] Cipresso, P., & Immekus, J. C. (2017). Back to
the future of quantitative psychology and
measurement: Psychometrics in the twenty-first
century. Frontiers in Psychology, 8, 2099.
[PubMed Central]
[8] Donnelly-Kehoe, P. A., Pascariello, G. O., &
Gomez, J. C. (2018). Looking for Alzheimer’s
disease morphometric signatures using machine
learning techniques. Journal of Neuroscience
Methods, 15(302), 24–34. [Google Scholar]
[9] Cipresso, P., Matic, A., Giakoumis, D., &
Ostrovsky, Y. (2015). Advances in
computational psychometrics. Computational
and Mathematical Methods in Medicine, 2015,
1. [Google Scholar]
[10] Angra, S., & Ahuja, S. (2017). Machine
learning and its applications: A review. In
Machine learning and its applications: A review
(pp. 57–60). [Google Scholar]
[11] Buckner, R. L., Andrews-Hanna, J. R., &
Schacter, D. L. (2008). The brain’s default
network: Anatomy, function, and relevance to
disease. Annals of the New York Academy of
Sciences, 1124, 1–38
